GLP-1 receptor agonists are medications that mimic this hormones effects but at a much stronger and longer-lasting level than what the body produces on its own
A 2022 analysis in JAMA Internal Medicine , for example, found that the use of GLP-1 RAs was associated with an increased risk for gallbladder or biliary diseases, especially when used at higher doses, for longer durations, and for weight loss
Im not craving nicotine anymore. And so this really set off, like, a wave of research in the addiction space of, you know, scientists thinking like, Okay, you know, we know that food reward pathways are overlapped, and we know that, oftentimes, thats what we see in addiction, too
Dietary fibre in Europe: current state of knowledge on definitions, sources, recommendations, intakes and relationships to health